Biotechnology Why Is Madrigal Pharmaceuticals Stock Trading Higher On Friday? – Madrigal Pharmaceuticals (NASDAQ:MDGL) Read more
Biotechnology Madrigal Pharmaceuticals Announces Publication of the Phase 3 MAESTRO-NASH Trial of Resmetirom in the New England Journal of Medicine – Madrigal Pharmaceuticals (NASDAQ:MDGL) Read more